Literature DB >> 12579062

Adverse drug events in trauma patients.

Harrison M Lazarus1, Jolene Fox, R Scott Evans, James F Lloyd, David J Pombo, John P Burke, Diana Handrahan, Marlene J Egger, Todd L Allen, Mark H Stevens.   

Abstract

BACKGROUND: Adverse drug events (ADEs) are noxious and unintended results of drug therapy. ADEs have been shown to be a risk to hospitalized patients. The purpose of this study was to determine the rate and nature of ADEs in trauma patients and to characterize the population at risk.
METHODS: An electronic medical record, a hospital wide computerized surveillance program, and a clinical pharmacist prospectively investigated ADEs in 4,320 trauma patients from 1996 through 1999.
RESULTS: The rate of ADEs in trauma patients (98/4320, 2.3%) was twice that of non-trauma hospital patients (1,111/96,218, 1.2%, p < 0.001). Traumatized females had ADEs 1.5 times more often than traumatized males (2.7% versus 1.8%, p = 0.052). The medication class most often associated with ADEs was analgesics with 54% involving morphine and 20% involving meperidine. The most common ADEs were nausea, vomiting, and itching. Only one ADE was directly attributed to a medical error.
CONCLUSIONS: Trauma patients are at double the risk for ADEs. Analgesics are particularly associated with ADEs and use should be carefully monitored.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579062     DOI: 10.1097/01.TA.0000051937.18848.68

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

1.  Comorbidity-polypharmacy score: a novel adjunct in post-emergency department trauma triage.

Authors:  Carla F Justiniano; David C Evans; Charles H Cook; Daniel S Eiferman; Anthony T Gerlach; Paul R Beery; David E Lindsey; Gary E A Saum; Claire V Murphy; Sidney F Miller; Thomas J Papadimos; Steven M Steinberg; Stanislaw P A Stawicki
Journal:  J Surg Res       Date:  2012-05-31       Impact factor: 2.192

2.  Comorbidity-Polypharmacy Score as Predictor of Outcomes in Older Trauma Patients: A Retrospective Validation Study.

Authors:  Ronnie N Mubang; Jill C Stoltzfus; Marissa S Cohen; Brian A Hoey; Christy D Stehly; David C Evans; Christian Jones; Thomas J Papadimos; Jennifer Grell; William S Hoff; Peter Thomas; James Cipolla; Stanislaw P Stawicki
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

3.  Evidence based development of bedside clinical drug rules for surgical patients.

Authors:  Maya A Ramrattan; Eveline B Boeker; Kim Ram; Desiree M T Burgers; Monica de Boer; Loraine Lie-A-Huen; Wilhelmina M C Mulder; Marja A Boermeester
Journal:  Int J Clin Pharm       Date:  2014-04-20

4.  Adverse drug events in surgical patients: an observational multicentre study.

Authors:  Monica de Boer; Eveline B Boeker; Maya A Ramrattan; Jordy J S Kiewiet; Marcel G W Dijkgraaf; Marja A Boermeester; Loraine Lie-A-Huen
Journal:  Int J Clin Pharm       Date:  2013-05-31

5.  Pre-injury polypharmacy as a predictor of outcomes in trauma patients.

Authors:  David C Evans; Anthony T Gerlach; Jonathan M Christy; Amy M Jarvis; David E Lindsey; Melissa L Whitmill; Daniel Eiferman; Claire V Murphy; Charles H Cook; Paul R Beery; Steven M Steinberg; Stanislaw Pa Stawicki
Journal:  Int J Crit Illn Inj Sci       Date:  2011-07

Review 6.  Occurrence and preventability of adverse drug events in surgical patients: a systematic review of literature.

Authors:  Eveline B Boeker; Monica de Boer; Jordy J S Kiewiet; Loraine Lie-A-Huen; Marcel G W Dijkgraaf; Marja A Boermeester
Journal:  BMC Health Serv Res       Date:  2013-09-28       Impact factor: 2.655

Review 7.  Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner's perspective.

Authors:  Stanislaw P Stawicki; Sarathi Kalra; Christian Jones; Carla F Justiniano; Thomas J Papadimos; Sagar C Galwankar; Scott M Pappada; John J Feeney; David C Evans
Journal:  J Emerg Trauma Shock       Date:  2015 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.